bioAffinity Technologies, Inc. (BIAF) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $1.04
• Market Cap: $4.90M
• EPS: $-13.21
• 52-Week High: $46.53
• 52-Week Low: $0.69

Market Sentiment

bioAffinity Technologies, Inc. currently has a Bullish sentiment score of 0.34.

About bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc. (BIAF) is a pioneering biotechnology company headquartered in San Antonio, Texas, dedicated to revolutionizing cancer diagnostics and treatment. Leveraging its proprietary non-invasive technologies, the firm focuses on enhancing early detection and targeted therapies to improve patient outcomes in oncology. With a strong commitment to innovation and research, bioAffinity is well-positioned to address significant challenges in cancer care, aiming to make meaningf...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for bioAffinity Technologies, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BIAF pay dividends?

bioAffinity Technologies, Inc. (BIAF) does not currently pay a regular dividend.

What is BIAF's market cap?

bioAffinity Technologies, Inc. (BIAF) has a market capitalization of $4.90M with a current stock price of $1.04.